论文部分内容阅读
对扁桃体鳞癌病人的处理迄今尚有争论。5年生存率报告各异,亦无充分资料表明其治疗效果。为此,作者复习了多年来有关扁桃体肿瘤治疗方法和结果的报道,并进行了对扁桃体癌治疗的前瞻性研究,着重分析Ⅲ、Ⅳ期癌的治疗情况。旨在比较各种治疗方法对扁桃体癌生存的影响。纳入此项研究计划的共174例患者,按TNM法分类:Ⅰ期(T_1N_0M_0)21例,Ⅱ期(T_2N_0M_0)19例,Ⅲ期(T_3N_0M_0,T_(1～3)N_0M_0)34例,Ⅳ期(T_4N_(0～1),N_2,N_3或M_1)100例。单纯放疗(RT)——((?))钴照射5500～6700rad81例,单用手术(S)治疗者19例。49例采用联合治疗(RT+S),即先行放疗(5000～6000rad),随后手术。25例则于化疗(C)后再行RT+S治疗——C+RT+S,化疗所用药物为氨甲喋呤、叶醛酸、顺氯氨铂及博来霉素。仅有12例完成了
Treatment of patients with tonsil squamous cell carcinoma has so far been controversial. The five-year survival report varies, and there is no sufficient data to demonstrate its therapeutic effect. To this end, the author reviewed the reports on tonsil tumor treatment methods and results for many years, and conducted a prospective study of the treatment of tonsil cancer, focusing on the analysis of the treatment of stage III and IV cancer. The aim was to compare the effects of various treatments on the survival of tonsillar cancer. A total of 174 patients included in the study were classified according to the TNM method: 21 cases of stage I (T_1N_0M_0), 19 cases of stage II (T_2N_0M_0), and 34 cases of stage III (T_3N_0M_0, T_(1-3)N_0M_0). (T_4N_(0~1), N_2, N_3 or M_1) 100 cases. Radiotherapy alone (RT) - ((?)) Cobalt irradiation in 5500 ~ 6700rad 81 cases, 19 cases were treated with surgery (S) alone. In 49 cases, combination therapy (RT+S) was used, ie, first radiotherapy (5000 to 6000 rad) followed by surgery. Twenty-five patients were treated with RT+S (C+RT+S) after chemotherapy (C). The drugs used for chemotherapy were methotrexate, uronic acid, cisplatin, and bleomycin. Only 12 cases have been completed